It is likely that either the HCV core leads to hepatic steatosis by means of modulating FABPl gene expression to inhibit MTP protein activity and VLDL secretion [38] or that downregulation of FABPl is a nonspecific phenomenon secondary to hepatic steatosis. Here, FABP1 is linked to Hepatic steatosis.